insomnia | CARLAT PUBLISHING

Clinical Update

New Medications for Insomnia

February 1, 2024

Garrett Rossi, MD. Inpatient/Consult Attending Psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.
Dr. Rossi has no financial relationships with companies related to this material.

The orexin antagonist—daridorexant, lemborexant, and suvorexant—may be safer than traditional hypnotics, but how well do they work?

Clinical Update

Managing Insomnia in Older Adults

December 31, 2023

Julia Cromwell, MD

Julia Cromwell, MD. Medical Director, Senior Adult Psychiatry Unit, Salem Hospital, Salem, MA.

Dr. Cromwell has no financial relationships with companies related to this material.

Treating insomnia in older adults often comes with harms. Here we review how to get the diagnosis right, how to optimize treatment without medications, and how to find safer and more affordable medications when needed.

Clinical Update

Music for Sleep

April 14, 2023

Jesse Koskey, MD.

Jesse Koskey, MD. Associate Clinical Professor, Department of Psychiatry and Behavioral Sciences, UC Davis Health, Sacramento, CA.

Dr. Koskey has no financial relationships with companies related to this material.

An alternative to hypnotics with a surprising effect size.

Improving Sleep in Children and Adolescents

February 19, 2023

Joshua Feder, MD and Mara Goverman

Learn how clinicians can enhance their patient’s quality of life by improving sleep outcomes.

Can CBD Work for PTSD?

September 25, 2022

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC. Ms. Lo, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Cannabidiol (CBD oil) is a popular self-remedy for anxiety and insomnia. A new study tests the drug in PTSD.

How to Safely Prescribe Z-Drugs

August 13, 2020

There’s good reason to be careful prescribing Z-drugs. Here’s an overview of Dr. Reban Aziz’s recent article in The Carlat Addiction Treatment Report.Safety Tips Go short-term or intermittent to reduce the potential for adverse events and withdrawal. Avoid for SUD or complex sleep disorders. Use as last resort after considering...

A New Contraindication for Ambien and the Z-Hypnotics

August 30, 2019

Chris Aiken, MD Talia Puzantian, PharmD, BCPP

Chris Aiken, MD Talia Puzantian, PharmD, BCPP Dr. Aiken and Dr. Puzantian have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA rarely issues absolute contraindications, but that’s where their language is tilting in a new warning on Z-Hypnotics. We look at the data behind their decision and offer six tips for safer prescribing of sleep medications.

Another Black Eye for Prazosin in PTSD?

August 1, 2019

Nicholas Rosenlicht, MD

Nicholas Rosenlicht, MD Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Recent trials cast doubt on prazosin’s role in PTSD, but there are reasons to doubt their results.

Safe Use of Gabapentin with Patients

June 19, 2019

Although there’s been a lot of discussion about gabapentin’s abuse potential, gabapentin substance use disorders are pretty rare, with one study finding that only 2% of 44,148 patients using gabapentin alone met criteria for sustained overuse (Peckham et al, Pharmacotherapy, in press). The one area where you should show caution,...